4,4,5,5-Tetramethyl-2-(1-naphthyl)-1,3,2-dioxaborolane>98.0%(GC)(T)1g

5-(Dimethylamino)-2-nitrobenzoic acid, 95%, 1g

6-Chloro-5-nitro-pyrimidine-2,4-diol, 95.0%, 10g

2-(1H-pyrazol-3-yl)pyrazine, 95.0%, 250mg

4-CHLORO-6-IODO-7-METHOXYQUINAZOLINE, 97.0%, 10g

tert-butyl (1R,4R)-5-benzyl-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate, 95.0%, 500mg

(6-Cyclopropylpyridin-3-yl)boronic acid, 95.0%, 5g

(2-methyl-2,3-dihydro-1H-indol-1-yl)acetic acid hydrochloride, 95.0%, 1g

2-Bromo-1-(m-tolyl)ethanone, 97%, 10g

2-(Hydrazinylmethyl)pyridine dihydrochloride, 95.0%, 250mg

Methanone, phenyl-2-pyridinyl-, 2-(5-chloro-2-pyridinyl)hydrazone, (E,E)-, 98%, 25mg

Mandatory signs in accordance with ISO 7010, Skin protection cream mandatory, 100 mm, 1 piece

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-4-carboxylate, 95.0%, 5g